| 5301 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
26 |
| 5302 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
52 |
| 5303 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
38 |
| 5304 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5305 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia – Relapse |
Hematology |
2019 |
Standard Therapy |
Germany |
51 |
| 5306 |
Apheresis |
Autologous |
Amyloidosis |
Hematology |
2019 |
Standard Therapy |
Germany |
60 |
| 5307 |
Apheresis |
Allogeneic |
Aplasia |
Hematology |
2019 |
Standard Therapy |
Poland |
51 |
| 5308 |
Apheresis |
Allogeneic |
Aplastic Anemia |
Hematology |
2019 |
Standard Therapy |
Poland |
16 |
| 5309 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
8 |
| 5310 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
46 |
| 5311 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
21 |
| 5312 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Germany |
28 |
| 5313 |
Apheresis |
Allogeneic |
B-Cell Chronic Lymphoblastic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
66 |
| 5314 |
Apheresis |
Autologous |
B-Cell Non-Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5315 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2019 |
Standard Therapy |
Poland |
2 |
| 5316 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2019 |
Standard Therapy |
Poland |
16 |
| 5317 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2019 |
Standard Therapy |
Poland |
3 |
| 5318 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5319 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5320 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
69 |
| 5321 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5322 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
60 |
| 5323 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
69 |
| 5324 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
23 |
| 5325 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
34 |
| 5326 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
37 |
| 5327 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
56 |
| 5328 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5329 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
56 |
| 5330 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
31 |
| 5331 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
54 |
| 5332 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
46 |
| 5333 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
54 |
| 5334 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5335 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
73 |
| 5336 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5337 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5338 |
Apheresis |
Autologous |
Embryonal Cell Carcinoma Of The Testicle |
Hematology |
2019 |
Standard Therapy |
Germany |
29 |
| 5339 |
Apheresis |
Allogeneic |
Extracranial Malignant Germ Cell Tumors |
Hematology |
2019 |
Standard Therapy |
Poland |
53 |
| 5340 |
Apheresis |
Allogeneic |
Glanzmann Thrombasthenia |
Hematology |
2019 |
Standard Therapy |
Poland |
11 |
| 5341 |
Apheresis |
Allogeneic |
High-Risk Myelodysplastic Syndrome |
Hematology |
2019 |
Standard Therapy |
Poland |
61 |
| 5342 |
Apheresis |
Allogeneic |
Histiocytosis X |
Hematology |
2019 |
Standard Therapy |
Poland |
14 |
| 5343 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5344 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
58 |
| 5345 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
28 |
| 5346 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
44 |
| 5347 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
1 |
| 5348 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
32 |
| 5349 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
34 |
| 5350 |
Apheresis |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
62 |
| 5351 |
Apheresis |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
69 |
| 5352 |
Apheresis |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Poland |
65 |
| 5353 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5354 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5355 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5356 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
68 |
| 5357 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
65 |
| 5358 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
54 |
| 5359 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5360 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5361 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5362 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
71 |
| 5363 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5364 |
Apheresis |
Allogeneic |
Mixed Phenotype Acute Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
59 |
| 5365 |
Apheresis |
Allogeneic |
Mixed Phenotype Acute Leukemia |
Hematology |
2019 |
Standard Therapy |
Poland |
49 |
| 5366 |
Apheresis |
Autologous |
Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy |
Hematology |
2019 |
Standard Therapy |
Germany |
36 |
| 5367 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2019 |
Standard Therapy |
Germany |
66 |
| 5368 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis Type I |
Metabolic |
2019 |
Standard Therapy |
Poland |
1 |
| 5369 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis Type Ii |
Metabolic |
2019 |
Standard Therapy |
Poland |
2 |
| 5370 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis Type Ii |
Metabolic |
2019 |
Standard Therapy |
Poland |
2 |
| 5371 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Poland |
52 |
| 5372 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Poland |
55 |
| 5373 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
68 |
| 5374 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
58 |
| 5375 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
58 |
| 5376 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
69 |
| 5377 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
58 |
| 5378 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
65 |
| 5379 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
52 |
| 5380 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5381 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
54 |
| 5382 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
51 |
| 5383 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
57 |
| 5384 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
52 |
| 5385 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
61 |
| 5386 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
68 |
| 5387 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5388 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5389 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
39 |
| 5390 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
52 |
| 5391 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
59 |
| 5392 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |
| 5393 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
40 |
| 5394 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
57 |
| 5395 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
53 |
| 5396 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
64 |
| 5397 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
70 |
| 5398 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
68 |
| 5399 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
56 |
| 5400 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2019 |
Standard Therapy |
Germany |
63 |